prorx semaglutide Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week 503b shuts down GLP-1 compounding while @martymakary is photographed holding bootleg # prorx semaglutide FDA issues warning

Image Credit: MillaF / Shutterstock Obesity is associated with several complications, such as hypertension, diabetes, osteoarthritis, cancer, cardiovascular death, and premature death

Patients were matched 1:1 using propensity scores to balance demographics, comorbidities, prior inflammatory bowel disease treatments, healthcare use, and baseline steroid exposure

Since April 2025, it has been illegal to prescribe and compound GLP-1 medications that are essentially a copy of FDA-approved drugs

Retatrutide is not currently licensed by the MHRA for weight loss in the UK, so it cannot legally be prescribed or supplied as an approved weight loss treatment